PYC Therapeutics (PYC Therapeutics) Net Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is PYC Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. PYC Therapeutics's Net Income for the six months ended in Dec. 2023 was A$-15.10 Mil. PYC Therapeutics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, PYC Therapeutics's net margin for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for PYC Therapeutics's Net Margin % or its related term are showing as below:

PLOGF's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -151.78
* Ranked among companies with meaningful Net Margin % only.

PYC Therapeutics Net Margin % Historical Data

The historical data trend for PYC Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PYC Therapeutics Net Margin % Chart

PYC Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Margin %

Get a 7-Day Free Trial

PYC Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PYC Therapeutics's Net Margin %

For the Biotechnology subindustry, PYC Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PYC Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PYC Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where PYC Therapeutics's Net Margin % falls into.

PYC Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

PYC Therapeutics's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-22.789	/	0
	=	%

PYC Therapeutics's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-15.095	/	0
	=	%

PYC Therapeutics (GREY:PLOGF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

PYC Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of PYC Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PYC Therapeutics (PYC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (GREY:PLOGF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

PYC:Australia

Address

6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009

Website

https://www.pyctx.com

PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.